131 related articles for article (PubMed ID: 8635140)
1. The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.
Takeda N; Diksic M; Yamamoto YL
Cancer; 1996 Mar; 77(6):1167-79. PubMed ID: 8635140
[TBL] [Abstract][Full Text] [Related]
2. Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.
Takeda N; Diksic M
J Neurooncol; 1999 Feb; 41(3):235-46. PubMed ID: 10359143
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter.
Chen ZP; Pan J; Huang Q; Sun ZF; Zhou LY; Wang AD
J Neurooncol; 2001 Jan; 51(1):19-24. PubMed ID: 11349876
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
5. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
[TBL] [Abstract][Full Text] [Related]
6. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771
[TBL] [Abstract][Full Text] [Related]
7. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
[TBL] [Abstract][Full Text] [Related]
8. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.
Hall DE; Moffat BA; Stojanovska J; Johnson TD; Li Z; Hamstra DA; Rehemtulla A; Chenevert TL; Carter J; Pietronigro D; Ross BD
Clin Cancer Res; 2004 Dec; 10(23):7852-9. PubMed ID: 15585617
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model.
Chen ZP; Wang G; Huang Q; Sun ZF; Zhou LY; Wang AD; Panasci LC
J Neurooncol; 1999 Aug; 44(1):7-14. PubMed ID: 10582663
[TBL] [Abstract][Full Text] [Related]
11. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures.
Grasso RJ; Johnson CE; Boler RK; Moore NA
Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide as a sensitizer of 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of brain tumors in the rat.
Salford LG; Pero RW; Aas AT; Brun A
Anticancer Drugs; 1992 Jun; 3(3):267-72. PubMed ID: 1525408
[TBL] [Abstract][Full Text] [Related]
13. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.
Chenevert TL; Stegman LD; Taylor JM; Robertson PL; Greenberg HS; Rehemtulla A; Ross BD
J Natl Cancer Inst; 2000 Dec; 92(24):2029-36. PubMed ID: 11121466
[TBL] [Abstract][Full Text] [Related]
14. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
Safdari H; Mompeon B; Dubois JB; Gros C
Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.
Mitsuki S; Diksic M; Conway T; Yamamoto YL; Villemure JG; Feindel W
J Neurooncol; 1991 Feb; 10(1):47-55. PubMed ID: 1902507
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.
Castellino RC; Elion GB; Keir ST; Houghton PJ; Johnson SP; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 2000; 45(4):345-9. PubMed ID: 10755324
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C
Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
Hamstra DA; Moffat BA; Hall DE; Young JM; Desmond TJ; Carter J; Pietronigro D; Frey KA; Rehemtulla A; Ross BD
J Neurooncol; 2005 Jul; 73(3):225-38. PubMed ID: 15980973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
